Medical News

RSS

Teenage girls more likely to perceive potential benefits of drug and alcohol use

Survey data released today by the Partnership for a Drug-Free America® and MetLife Foundation found that teenage girls are more likely than teenage boys to perceive potential benefits from drug use and drinking, making teen girls more vulnerable to drug and alcohol abuse.

29 Jun 2010

BIND Biosciences announces $12.4 million Series C-1 financing

BIND Biosciences, Inc. (BIND), a privately held biopharmaceutical company developing best in class therapeutics based on its proprietary targeted nanotechnology platform, announced today that it has secured a $12.4 Million Series C-1 financing. This financing included all of BIND's current investors (including Polaris Venture Partners, Flagship Ventures, ARCH Venture Partners, NanoDimension and DHK Investments) as well as a new venture investor, Endeavour Vision, and private investors.

29 Jun 2010

New tool could aid in diagnosing Alzheimer's, track disease progression

A trial of a novel radioactive compound readily and safely distinguished the brains of Alzheimer's disease patients from healthy volunteers on brain scans and opens the doors to making such imaging available beyond facilities that can manufacture their own radioactive compounds.

29 Jun 2010

First Edition: June 29, 2010

In this Kaiser Health News consumer column, Michelle Andrews writes: "Sarah Rose Nordgren works 25 to 30 hours a week as a waitress at an upscale restaurant in Chapel Hill, N.C. She also tutors high- schoolers on their college entrance essays and has an editorial internship at a book publisher. But if something were to go seriously wrong with her health, she'd be in trouble because none of her three jobs offers health insurance" (Kaiser Health News).

29 Jun 2010

Rosiglitazone therapy associated with increased risk for heart attack: Study

Eleven years after the introduction of the diabetes drug rosiglitazone, data from available clinical trials demonstrate an increased risk for heart attack associated with its use and suggest an unfavorable benefit-to-risk ratio, according to a report posted online today that will appear in the July 26 print issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

29 Jun 2010

Sedentary white women are more likely to become obese

Obesity is climbing steadily among American women and an inactive lifestyle is one risk factor. A new study finds that sedentary white women are more apt to become obese than are sedentary African-American women.

29 Jun 2010

Statins does not reduce death risk in high-risk individuals without heart disease

A meta-analysis of previously published studies finds no evidence that statins are associated with a reduced risk of death among individuals at risk for but with no history of cardiovascular disease, according to a report in the June 28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals

29 Jun 2010

Lantus and Apidra improve outcomes, decrease glycemic variability: Study

Sanofi-aventis announced today results of a study which demonstrated that patients using Lantus® (insulin glargine [rDNA origin] injection) once-daily and Apidra® (insulin glulisine [rDNA origin] injection) before meals reported improved patient reported outcomes and decreased glycemic variability versus premix analog insulin. Two abstracts from this study were highlighted at the American Diabetes Association's 70th Annual Scientific Sessions (ADA).

29 Jun 2010

Phytonutrient-based medical food and heart-healthy diet reduce CVD risk factors: Study

New research presented at the American Diabetes Association's 70th Scientific Sessions in Orlando, Florida on June 27, 2010 suggests that a medical food developed by Metagenics, Inc. called UltraMeal® PLUS 360° enhances the cardiovascular disease (CVD) risk-lowering benefits of a Mediterranean-style low-glycemic-load diet.

29 Jun 2010

Chronic migraine sufferers experience greater LPT in workplace

A new analysis from the American Migraine Prevalence and Prevention Study, one of the largest longitudinal studies of headache, indicates that employees suffering from Chronic Migraine (CM) experience increased lost productive time (LPT) in the workplace.

29 Jun 2010

Study investigates efficacy of SWV measurement in evaluation of NASH pathophysiology using ultrasound

Nonalcoholic steatohepatitis (NASH) is manifestation of metabolic syndrome in the liver and is a pandemic over the globe especially in the developed countries, based on a high calorie diet and sedentary life style. As in the other types of chronic hepatitis, collagen fibers continuously accumulate in the liver through the course of NASH toward cirrhosis and hepatocellular carcinoma development.

29 Jun 2010

Health researchers initiate new study to reduce tobacco use

A team of health researchers from The University of Nottingham are spearheading a new project to reduce tobacco use in an area which has one of the highest rates of smoking in the country.

29 Jun 2010

Sapienza University researchers gain access to Elsevier's Reaxys workflow solution for research chemists

Elsevier and Sapienza University of Rome today announced a new agreement, providing researchers at the university with access to Reaxys, Elsevier's workflow solution for research chemists. Reflecting the way chemists think and work, Reaxys will enable researchers at Sapienza to quickly find the chemistry relevant for their needs and thereby raise their performance and output.

29 Jun 2010

Majority of doctors resort to defensive medicine practices, says survey

A survey by Mount Sinai School of Medicine researchers has found that 91 percent of physicians believe concerns over malpractice lawsuits result in "defensive medicine," ordering more tests and procedures than necessary as a protective measure. The study, which questioned 2,416 physicians, is published in the June 28 edition of Archives of Internal Medicine.

29 Jun 2010

AMAG, Takeda provide regulatory and clinical update for Feraheme Injection

AMAG Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited today provided a regulatory and clinical update for Feraheme® (ferumoxytol) Injection for intravenous (IV) use.

29 Jun 2010

AVEO Pharmaceuticals joins Russell 2000 Index and S&P MidCap 400

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that the company has been added to the Russell 2000® Index, as part of the annual reconstitution of the entire Russell family of indexes that took place on June 25, 2010 following the close of the market.

29 Jun 2010

Serotonin promotes beta cell expansion during pregnancy, offers possible cure for type 1 diabetes

Researchers funded by JDRF have discovered that the hormone, serotonin, may be involved in the increase of insulin-producing beta cells during pregnancy.

29 Jun 2010

U.S. Supreme Court declines to hear appeals in civil racketeering lawsuit against cigarette manufacturers

The U.S. Supreme Court today declined to hear appeals in the federal government's civil racketeering lawsuit against cigarette manufacturers. Today's decision upholds the trial court's historic verdict that the cigarette manufacturers are racketeers and have engaged in a decades-long conspiracy to deceive the American public and target children with their deadly and addictive products. That verdict is now final and undeniable: The cigarette manufacturers have been found guilty of engaging in a deadly fraud that is unprecedented in our nation's history.

29 Jun 2010

New earplug with built-in computer allows speech to pass; shuts out unwanted noise

An earplug with a built-in computer that allows speech to pass but shuts out unwanted and hazardous noise will make life easier in noisy environments.

29 Jun 2010

Tranzyme reports positive results from TZP-102 Phase 2 study in diabetic patients with gastroparesis

Tranzyme Pharma announced positive top-line results today from a Phase 2, double-blind, placebo-controlled study evaluating TZP-102 capsules in diabetic patients with gastroparesis, a serious disorder characterized by the inability of the stomach to empty food efficiently. The study achieved a clinically meaningful and statistically significant improvement in critical gastroparesis-related symptoms. All three TZP-102 doses tested were effective, safe and well tolerated.

29 Jun 2010

Medical News

Teenage girls more likely to perceive potential benefits of drug and alcohol use

BIND Biosciences announces $12.4 million Series C-1 financing

New tool could aid in diagnosing Alzheimer's, track disease progression

First Edition: June 29, 2010

Rosiglitazone therapy associated with increased risk for heart attack: Study

Sedentary white women are more likely to become obese

Statins does not reduce death risk in high-risk individuals without heart disease

Lantus and Apidra improve outcomes, decrease glycemic variability: Study

Phytonutrient-based medical food and heart-healthy diet reduce CVD risk factors: Study

Chronic migraine sufferers experience greater LPT in workplace

Study investigates efficacy of SWV measurement in evaluation of NASH pathophysiology using ultrasound

Health researchers initiate new study to reduce tobacco use

Sapienza University researchers gain access to Elsevier's Reaxys workflow solution for research chemists

Majority of doctors resort to defensive medicine practices, says survey

AMAG, Takeda provide regulatory and clinical update for Feraheme Injection

AVEO Pharmaceuticals joins Russell 2000 Index and S&P MidCap 400

Serotonin promotes beta cell expansion during pregnancy, offers possible cure for type 1 diabetes

U.S. Supreme Court declines to hear appeals in civil racketeering lawsuit against cigarette manufacturers

New earplug with built-in computer allows speech to pass; shuts out unwanted noise

Tranzyme reports positive results from TZP-102 Phase 2 study in diabetic patients with gastroparesis

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News